WVP
SIOX

Worth Venture Partners’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Worth Venture Partners’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27,700
Closed -$2K – 123
2019
Q4 		$2K Buy
27,700
+13,400
+94% +$74.3K ﹤0.01% 87
2019
Q3 		$13K Buy
+14,300
New +$98.6K 0.01% 91
2017
Q4 		– Sell
-20,313
Closed -$4K – 154
2017
Q3 		$4K Buy
20,313
+7,413
+57% +$1.25M ﹤0.01% 122
2017
Q2 		$1.43M Buy
12,900
+4,487
+53% +$787K 1.24% 13
2017
Q1 		$599K Buy
+8,413
New +$882K 0.53% 42

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return